Oral Application Of Bacterial Lysate In Infancy Decreases The Risk Of Infantile Atopic Eczema In A Subgroup Of Children With Paternal Atopy

Oral Application Of Bacterial Lysate In Infancy Decreases The Risk Of Infantile Atopic Eczema In A Subgroup Of Children With Paternal Atopy

In a double-blind placebo-controlled trial, 553 healthy infants with at least single positive heredity for atopy were treated daily from week 5 until the end of month 7 by oral route with bacterial lysate (Pro-Symbioflor) containing heat-killed gram-negative E. coli and grampositive Enterococcus fae...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2011-02, Vol.127 (2), p.AB34-AB34
Hauptverfasser: Lau, S.G, Gerhold, K, Sulser, C, Rossberg, S, Witt, I, Wauer, J, Beschorner, J, Bunikowski, R, Zimmermann, K, Menke, G, Wahn, U
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Children & youth
Eczema
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In a double-blind placebo-controlled trial, 553 healthy infants with at least single positive heredity for atopy were treated daily from week 5 until the end of month 7 by oral route with bacterial lysate (Pro-Symbioflor) containing heat-killed gram-negative E. coli and grampositive Enterococcus faecalis (1.5-4.5 x 107 bacteria/ml).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2010.12.146